Oak Associates Funds
Live Oak Health Sciences Fund
$54.37M
Avg Monthly Net Assets
$50.92M
Total Assets
$44K
Total Liabilities
$50.87M
Net Assets
Live Oak Health Sciences Fund is a Mutual Fund in Oak Associates Funds
,
based in Ohio,
United States of America.
The fund has one share class
and monthly net assets of $54.37M.
On June 28th, 2024 it reported 33 holdings, the largest
being Mount Vernon Liquid Assets Portfolio, LLC (19.1%), Regeneron Pharmaceuticals, Inc. (5.6%) and Mckesson Corp. (5.5%).
Data provided by Fincoded.
Share Classes
Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
---|---|---|---|
Live Oak Health Sciences Fund | C000017877 | LOGSX |
Holdings
From latest NPORT-P, filed June 28th, 2024 for period ending April 30th, 2024.
Historic holdings data available from Fincoded.
Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
---|---|---|---|---|---|---|
Amgen, Inc. (Amgen Inc.) | Long | Equity-common | US | $2M | 9K | 4.79 |
Bio-Rad Laboratories, Inc. | Long | Equity-common | US | $905K | 3K | 1.78 |
Biogen, Inc. (Biogen Inc) | Long | Equity-common | US | $1M | 5K | 2.11 |
Cardinal Health, Inc. | Long | Equity-common | US | $2M | 18K | 3.68 |
Cencora Inc. | Long | Equity-common | US | $3M | 11K | 5.26 |
Centene Corp. (Centene Corporation) | Long | Equity-common | US | $2M | 24K | 3.40 |
Cigna Group/The (The Cigna Group) | Long | Equity-common | US | $2M | 6K | 4.35 |
Danaher Corp. (Danaher Corporation) | Long | Equity-common | US | $2M | 6K | 3.09 |
Elevance Health, Inc. (Elevance Health Inc.) | Long | Equity-common | US | $2M | 4K | 4.08 |
Ensign Group, Inc./The (Ensign Group Inc) | Long | Equity-common | US | $1M | 10K | 2.29 |
Exelixis, Inc. | Long | Equity-common | US | $2M | 84K | 3.87 |
Gilead Sciences, Inc. | Long | Equity-common | US | $894K | 14K | 1.76 |
Humana, Inc. (Humana Inc.) | Long | Equity-common | US | $1M | 4K | 2.33 |
Incyte Corp. (Incyte Corporation.) | Long | Equity-common | US | $827K | 16K | 1.63 |
Intuitive Surgical, Inc. (Intuitive Surgical Inc.) | Long | Equity-common | US | $2M | 5K | 3.64 |
Jazz Pharmaceuticals PLC | Long | Equity-common | IE | $931K | 8K | 1.83 |
Johnson & Johnson | Long | Equity-common | US | $1M | 8K | 2.41 |
Laboratory Corp of America Holdings | Long | Equity-common | US | $1M | 7K | 2.58 |
McKesson Corp. | Long | Equity-common | US | $3M | 5K | 5.54 |
Medtronic PLC | Long | Equity-common | IE | $1M | 13K | 2.00 |
Merck & Co., Inc. | Long | Equity-common | US | $2M | 14K | 3.55 |
Molina Healthcare, Inc. | Long | Equity-common | US | $2M | 5K | 3.49 |
Mount Vernon Liquid Assets Portfolio, LLC | Long | Short-term investment vehicle | US | $10M | – | 19.10 |
Novartis AG | Long | Equity-common | CH | $2M | 17K | 3.28 |
Prime Solutions 5% 5/1/24 | Long | Repurchase agreement | US | $318K | – | 0.63 |
Progyny, Inc. (Progyny Inc) | Long | Equity-common | KY | $1M | 37K | 2.32 |
Regeneron Pharmaceuticals, Inc. | Long | Equity-common | US | $3M | 3K | 5.58 |
Revvity Inc | Long | Equity-common | US | $2M | 15K | 3.02 |
Stryker Corp. (Stryker Corporation) | Long | Equity-common | US | $1M | 3K | 2.30 |
Thermo Fisher Scientific, Inc. (Thermo Fisher Scientific Inc) | Long | Equity-common | US | $2M | 3K | 3.77 |
United Therapeutics Corp. (United Therapeutics Corporation) | Long | Equity-common | US | $2M | 7K | 3.44 |
UnitedHealth Group, Inc. (UnitedHealth Group Inc.) | Long | Equity-common | US | $2M | 3K | 3.20 |
Vertex Pharmaceuticals, Inc. (Vertex Pharmaceuticals Incorporated) | Long | Equity-common | US | $2M | 4K | 3.03 |
Address
Oak Associates Funds
3800 Embassy Parkway
Suite 310
Akron
Ohio
44333-8334
United States of America
Websites
Directors
Susan F. Akers
David J. Gruber
Michael R. Shade
James D. Oelschlager
Pauline F. Ramig
Transfer Agents
Ultimus Fund Solutions, LLC
Pricing Services
Intercontinental Exchange, Inc.
Custodians
U.S. Bank, N.A.
Shareholder Servicing Agents
Ultimus Fund Solutions, LLC
Admins
Ultimus Fund Solutions, LLC
Brokers
INSTINET, LLC